Compudose by is a Animal medication manufactured, distributed, or labeled by Elanco US Inc., Ivy Animal Health, Inc., Bayer AG, Hebei Jianmin Starch Glucose Co., Ltd. . Drug facts, warnings, and ingredients follow.
Insert one implant under the skin of the ear.
To load the Compudose/Encore Implanter remove the cartridge from the package, release the latch on the magazine, open and insert the cartridge. (Figure 1)
Close the magazine and latch. Advance the cartridge to the next implant by inserting the thumb into the magazine opening and turning the cartridge to the next stop.
Use a sharp needle. The needle should be cleaned and sterilized between each injection by wiping the exterior with a sponge, cloth, or gauze saturated with an appropriate disinfectant. The presence of excessive moisture inside the needle may result in dissolving the oxytetracycline (OTC) from the implant surface and contribute to accumulation of OTC inside the needle.
The implant should be deposited under the skin on the back side of the middle third of the ear. It should be placed between the skin and cartilage, avoiding major blood vessels.
Grasping the tip of the ear with one hand and the implanter in the other, penetrate the skin in the outer third of the ear. (see Figure 2)
IMPORTANT: Do not penetrate cartilage.
Upon penetration, the needle should be fully inserted (Figure 3) between the skin and cartilage, avoiding major blood vessels. Full insertion of the needle is important to maximize implant retention.
After repeated use, sufficient oxytetracycline (OTC) from the implant may accumulate inside the needle to impede implant passage. Periodic removal of the needle from the device and washing it in water will prevent such accumulation. Before reusing, the needle should be disinfected and allowed to dry after shaking vigorously to remove excess water or disinfectant.
Proper Position
CAUTION: To maximize implant retention:
The needle has been scientifically designed to maximize retention. When it becomes dull, use a new needle. If the needle is resharpened, sharpen only the point.
Failure to follow antiseptic implanting procedures, particularly when the ears are contaminated with fecal material, may result in infection and excessive implant loss. Implanting cattle during wet weather may increase infection and implant loss.
Carefully check the ears for implant loss approximately 4 weeks after implantation. If loss occurs, reimplant using recommended procedures.
CAUTION: Increased sexual activity (bulling, riding and excitability) has been reported in animals implanted with Compudose. Implanted animals should be observed for such signs particularly during the first few days after implanting and animals being excessively ridden (bullers) should be removed to prevent physical injury. Vaginal and rectal prolapse have been reported in heifers implanted with Compudose.
CAUTION: Do not use in animals intended for breeding purposes.
Compudose Implants are supplied in cartridges of 20 implants each.
NADA 118-123, Approved by FDA
Manufactured by a non-sterilizing process.
Compudose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
Distributed by Elanco US,
Inc. Greenfield, IN 46140, USA
Product of Germany
To report adverse events, access medical information, or to obtain additional product information, call 1-800-428-4441
COMPUDOSE
estradiol, oxytetracycline implant |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Elanco US Inc. (966985624) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
COMPUDOSE 73387047 1259086 Dead/Cancelled |
Eli Lilly and Company 1982-09-20 |
COMPUDOSE 73138070 1096435 Live/Registered |
ELI LILLY AND COMPANY 1977-08-18 |